ADIM
EXPE icon

Alpha DNA Investment Management’s Expedia Group EXPE Stock Holding History

Alpha DNA Investment Management’s Portfolio EXPE Stock Details EXPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9,916
Closed -$1.62M – 121
2021
Q2 		$1.62M Buy
+9,916
New +$1.7M 1.11% 26

Other funds holding EXPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
MCM
Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Alpha DNA Investment Management's EXPE Position: Q3 2021 in Review

Alpha DNA Investment Management sold out of Expedia Group (EXPE) in Q3 2021, closing a stake of 9,916 shares — an estimated $1.62M sold.

Alpha DNA Investment Management first reported a position in EXPE in Q2 2021 and held it in 1 quarter. The position peaked at $1.62M in Q2 2021. 727 funds tracked by Wall St. Rank hold EXPE as of Q3 2021.

  • Alpha DNA Investment Management reported no remaining Expedia Group position as of Q3 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 9,916 Expedia Group shares in Q3 2021, an estimated $1.62M.
  • Alpha DNA Investment Management first reported a position in Expedia Group in Q2 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Expedia Group position peaked at $1.62M in Q2 2021.
  • 727 funds tracked by Wall St. Rank held Expedia Group as of Q3 2021.

Based on Alpha DNA Investment Management's 13F filing for Q3 2021, filed 10 Nov 2021.